BioMarin Pharma (BMRN) Tops Q3 EPS by 4c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $66.64 --0%
Financial Fact:
Provision for income taxes: -24.02M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Provision for income taxes: -24.02M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q3 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $408.7 million versus the consensus estimate of $435.89 million.
GUIDANCE:
BioMarin Pharma sees Q4 2021 revenue of $1.82-1.88 billion, versus the consensus of $1.85 billion.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
- HA Sustainable Infrastructure Ca (HASI) PT Lowered to $45 at BofA Securities
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
